Skip to content
easybpt
Browse topics

Nephrology

Renal biopsy

When a kidney biopsy changes management and when serology can replace it, contraindications, preparing the patient (BP, antithrombotics, desmopressin), what light, immunofluorescence and electron microscopy each add, and the bleeding risks from the 2020 meta-analysis.

Tier 2Medical sciences concept

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions8 flashcards

At a glance

  • A biopsy is worth doing when the result would change treatment or prognosis and the kidneys are still salvageable.
  • Main indications: adult nephrotic syndrome, nephritic syndrome or RPGN, unexplained AKI that isn't recovering, proteinuria over 0.5 g/day with haematuria, systemic disease with kidney involvement (lupus, vasculitis, myeloma), and transplant dysfunction.
  • Serology sometimes replaces it: a positive anti-PLA2R with typical membranous nephropathy, or a confirmed genetic diagnosis of Alport syndrome.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions8 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Turnstile bot check on sign-in and signed-out feedback

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.